View Archived Issues

Jan. 18, 2019

Vol. 18
No. 13


Editor’s Note

In observance of Martin Luther King Day Holiday, Drug Industry Daily will not be published Monday, Jan. 21. The next issue will be published Tuesday, Jan. 22. Read More

FDA Releases Naloxone Drug Facts Labels to Spur OTC Development

FDA Commissioner Scott Gottlieb announced on Thursday that the agency has developed easy-to-understand model drug facts labels (DFLs) to encourage drugmakers to develop an OTC version of the opioid overdose treatment naloxone. Read More

FDA Panel Splits on Sanofi’s Diabetes NDA

An FDA advisory committee deadlocked Thursday on the safety profile for Sanofi’s NDA for type 1 diabetes drug sotagliflozin. Read More

New Coalition to Lobby Against Patent Misuse by Branded Companies

A new coalition of advocacy groups has united to oppose misuse of patents by branded drugmakers. Read More